Ralliant Corporation (RAL)
Healthcare › Industrial Instruments For Measurement, Display, and Control
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 53% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 14.8% — below-average profitability
Ralliant Corporation (RAL) is a Healthcare company operating in Industrial Instruments For Measurement, Display, and Control, listed on the NYSE , with a market capitalisation of $4.6 billion . Key value metrics: P/E ratio 18.8, P/B ratio 2.79, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Ralliant Corporation — Fundamental Analysis Summary
Ralliant Corporation (RAL) is currently trading 53% above its Graham Number of $26.71, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 18.8x.
On financial health, RAL shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 14.8% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.70.
StockPik's composite Value Score for RAL is 64/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
RAL reports a solid gross margin of 51.1% (sector average: 33.5%) and a solid operating margin of 15.6%.
RAL shows revenue declining at 4% year-over-year, with earnings declining at 445%.
RAL pays a modest dividend yield of 0.2%.